Page last updated: 2024-10-15

merrilactone a

Description

merrilactone A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164512929
MeSH IDM0429253

Synonyms (7)

Synonym
merrilactone a
DTXSID101028870
(+)-merrilactone a
dzs2xp3qh2 ,
unii-dzs2xp3qh2
(2s,2as,5as,5bs,8as,8br,10s)-tetrahydro-10-hydroxy-2,5b,8a-trimethyl-2,5a-ethano-2h,5ah,8h-furo(3',4':4,5)oxeto(3',2':2,3)cyclopenta(1,2-b)furan-4,8(3h)-dione
301842-37-5

Effects

ExcerptReference
"Merrilactone A (1) has been shown to possess neurotrophic activity and thus is expected to hold therapeutic potential in the treatment of neurodegeneration diseases. "( Total synthesis of merrilactone A.
Hirama, M; Inoue, M; Sato, T, 2003
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (62.50)29.6817
2010's3 (18.75)24.3611
2020's3 (18.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]